Avantor, Inc. SEC Filings

Avantor, Inc. reported Q2 2026 net sales of $1,692.3 million, up 0.5% year over year, with organic net sales down 0.4%. Net income was $38.1 million, down from $64.7 million, and net income margin was 2.3%. Adjusted net income was $143.3 million and Adjusted EBITDA $254.3 million, for a 15.0% Adjusted EBITDA margin.

VWR Distribution & Services net sales were $1,240.5 million, up 2.7% reported and 1.7% organically, while Bioscience & Medtech Products net sales declined 5.1% to $451.8 million, with a 5.6% organic decrease. Adjusted Operating Income was $126.4 million for VWR and $117.6 million for Bioscience & Medtech, with margins of 10.2% and 26.0%, respectively.

Operating cash flow was $178.2 million and free cash flow $142.8 million, which the company used in part to repay $112.1 million of debt. Total debt was $3,715.4 million and cash and cash equivalents $306.8 million, resulting in Adjusted net leverage of 3.3x. Avantor raised its 2026 organic revenue growth guidance to a range of -0.5% to +0.5% and its Adjusted EPS guidance to $0.80–$0.83.

Avantor, Inc. executive Claudius Sokenu, EVP, Chief Legal & Compliance, reported a tax-related disposition where 1,201 shares of common stock were withheld by the issuer at $11.44 per share to cover RSU vesting tax obligations, leaving 251,228 shares held directly.

Avantor, Inc., through its wholly owned subsidiary Avantor Funding, Inc., entered into Amendment No. 15 to its Credit Agreement on July 14, 2026. Under this amendment, the subsidiary obtained a new tranche of senior secured Euro-denominated term loans totaling €374,208,296.62, designated as Incremental B-7 Euro Term Loans.

These loans bear interest at the floating EURIBO Rate + 2.00% per annum and replace certain existing senior secured euro term loans that carried a rate of EURIBO Rate + 2.50%, while maintaining the same final stated maturity of October 9, 2032. The Incremental B-7 Euro Term Loans are guaranteed by the same subsidiaries and secured by the same collateral as the existing credit facilities on a pari passu basis.

The amendment also introduces a 1.00% prepayment premium if, within six months of the effective date, the Borrower prepays, replaces or refinances these Incremental B-7 Euro Term Loans with broadly syndicated term B credit facilities that have a lower effective yield, excluding transactions linked to a change of control or certain transformative acquisitions.

Avantor, Inc. reported that executive Corey Walker, President of VWR Distribution & Services, had 3,010 shares of Common Stock withheld at $9.58 per share to cover tax withholding obligations tied to vesting restricted stock units (RSUs). This was not an open-market sale but a tax-related share disposition. After this withholding, Walker directly holds 384,535 shares of Avantor common stock.

Avantor, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 7, 2026. Stockholders elected nine directors to one-year terms expiring at the 2027 annual meeting, with each nominee receiving substantially more votes for than against.

Stockholders approved, on an advisory basis, the 2025 compensation of the company’s named executive officers and chose one year as the preferred frequency for future advisory votes on executive pay. Based on this, the board will hold say-on-pay votes annually until the next required frequency vote, expected at the 2032 annual meeting.

Stockholders also ratified the appointment of Deloitte & Touche LLP as Avantor’s independent registered public accounting firm for the year ending December 31, 2026.

Murthy Mala reported acquisition or exercise transactions in this Form 4 filing.

Avantor director Mala Murthy reported an equity award of company stock. She received 25,270 shares of Avantor common stock as a grant at no cash cost, increasing her direct holdings to 69,479 shares after the transaction.

According to a footnote, the grant is in the form of restricted stock units that will vest on May 7, 2027, meaning the award is part of her long-term compensation and becomes fully owned only after the vesting date is reached.

Avantor, Inc. director Gregory T. Lucier reported two stock acquisitions. He received a grant of 25,270 restricted stock units, which vest on May 7, 2027, as equity compensation. In a separate open-market transaction, a trust for which he serves as trustee and is a beneficiary purchased 10,000 shares of common stock at a weighted average price of about $8.32, with individual trades between $8.30 and $8.32. Following these transactions, the trust holds 60,000 shares indirectly attributed to him, while his direct holdings total 34,006 shares. He disclaims beneficial ownership of the trust shares except for his pecuniary interest.

Dingemans Simon reported acquisition or exercise transactions in this Form 4 filing.

Avantor director Simon Dingemans reported an equity compensation grant of 25,270 shares of Common Stock. The award is in the form of restricted stock units that vest on May 7, 2027, meaning the shares are delivered only if he remains eligible through that date.

Following this grant, Dingemans directly holds 31,495 shares of Avantor stock. The transaction carried no cash purchase price and reflects a routine, stock-based component of his director compensation rather than an open-market buy or sell.